| Melanoma stage | 5-year survival (%) |
|---|
| Stage 0 melanoma in situ, melanoma cells only in the epidermis, no invasion | 100 |
Stage 1A melanoma with Breslow thickness 1 mm without ulceration/lymph node involvement | 95 |
Stage 1 B melanoma with Breslow thickness 1 mm with ulceration/no lymph node involvement or 1.01-2 mm Breslow without ulceration/lymph node involvement | 91 |
| Stage 2 A melanoma with Breslow thickness > 1 mm to 2.01 mm without ulceration/metastases or 2.01-4 mm without ulceration/lymph node involvement | 77-79 |
| Stage 2 B melanoma 2.01-4 mm Breslow with ulceration/no lymph nodes or > 4 mm without ulceration/lymph nodes | 63-67 |
| Stage 2 C melanoma >4 mm Breslow with ulceration/no lymph nodes | 45 |
| Stage 3 A Any Breslow without ulceration/with 1-3 lymph node micrometastases | 63-70 |
| Stage 3 B Any Breslow with ulceration and 1-3 lymph node micrometastases or any Breslow without ulceration plus 1-3 lymph node macrometastases | 46-59 |
| Stage 3 C Any Breslow, without ulceration plus 1-3 macrometastases or ≥ 4 metastatic lymph nodes or melanoma satellites | 24-29 |
| Stage 4 melanoma with metastases in the skin, subcutaneous tissue or lymph nodes at distant sites or metastases in visceral organs | 7-19 |